Affiliate disclosure: This article contains Amazon affiliate links. As an Amazon Associate, Glowstice earns from qualifying purchases — at no extra cost to you. Our editorial recommendations are independent of these partnerships. Learn more.
Malassezia folliculitis is one of dermatology's most reliably misdiagnosed conditions. It presents as a crop of small, uniform, itchy bumps that look enough like acne that most people treat it as acne — and acne treatment, particularly anything oil-based or antibiotic, frequently makes it worse. The condition is well characterised in the clinical literature and the treatment is straightforward once you know what you're treating. The online community around it has also generated a large body of ingredient folklore that deserves separating from the medicine.
What It Actually Is
Malassezia is a genus of lipophilic — oil-loving — yeasts that live on essentially everyone's skin as normal flora. Under the right conditions they proliferate inside the hair follicle, and the resulting inflammation produces the eruption known as Malassezia folliculitis, or Pityrosporum folliculitis in older literature.
'Fungal acne' is the popular name. It is a genuinely useful label for search purposes and a slightly misleading one clinically, because the condition is not acne at all — it is an infection of the pilosebaceous unit by a yeast rather than the four-mechanism process that drives acne vulgaris. It is frequently described in the literature as an underdiagnosed mimicker of acneiform eruptions, which is exactly right.
The yeast feeds on skin lipids, which explains most of its behaviour: it favours oily areas, it flares in heat and humidity, it worsens under occlusion, and it is aggravated by oil-rich products. It also flares after broad-spectrum antibiotics, which suppress competing bacteria and leave the yeast more room — one reason acne patients on long antibiotic courses sometimes develop it.
How to Tell It Apart From Acne
Several signals, none individually definitive but collectively fairly reliable.
Uniformity. Malassezia folliculitis produces small papules and pustules of strikingly similar size — typically 1 to 2mm — in crops. Acne is heterogeneous: blackheads, whiteheads, papules, and the occasional nodule all at once, at different stages.
No comedones. This is the most useful single distinction. Malassezia folliculitis does not produce blackheads. If you have blackheads, you have at least some acne vulgaris.
Itch. Acne is rarely itchy. Malassezia folliculitis frequently is, and that symptom is a genuine flag.
Distribution. It favours the forehead, hairline, chest, upper back, and shoulders more than the classic acne zones of the lower face and jaw.
And the diagnostic clue that brings most people to this article: it does not respond to acne treatment, or actively worsens on it. If you've run twelve weeks of adapalene and benzoyl peroxide on something that looks like acne and it hasn't moved, this is worth considering.
The caveat worth stating plainly: these two conditions co-exist frequently, and a dermatologist can confirm with a simple skin scraping and microscopy. Self-diagnosis from an article is a starting hypothesis, not a conclusion.
Related Reading
Editor's Product Picks
Affiliate links — we earn a small commission at no extra cost to you.
The Ordinary 100% Plant-Derived Squalane Oil
~$8–$10
View on Amazon →
The Ordinary Niacinamide 10% + Zinc 1%
~$7–$10
View on Amazon →What Actually Works
The evidence here is unusually clean for a skin condition this widely self-treated.
Topical ketoconazole is the first-line intervention, and a systematic review covering seven studies and 689 participants reported clearance rates of roughly 80–90% with ketoconazole 2% cream used once daily for two weeks. That is a strong result. The most accessible form for most people is ketoconazole 1% anti-dandruff shampoo used as a short-contact body and face treatment — applied, left for a few minutes, rinsed — which is the standard community approach and a clinically reasonable one.
Zinc pyrithione is the gentler alternative, disrupting yeast cell membranes at concentrations around 0.3–2%. It is generally better tolerated than ketoconazole and a sensible option for sensitive skin, though it is the weaker agent.
Selenium sulfide is a third topical option in the same family.
Oral antifungals — typically itraconazole or fluconazole — are reserved for extensive or stubborn cases and are prescription-only. The literature notes oral treatment has proven superior to topical for clearance, which is why it's the escalation path rather than the starting point.
A note on what to expect: this responds fast. Improvement within one to two weeks is typical, and that speed is itself diagnostic — if four weeks of consistent antifungal treatment does nothing, the diagnosis is probably wrong.
On 'Fungal Acne Safe' Ingredient Lists
This is where I want to be careful, because the community framework around this condition is genuinely useful and is also routinely presented as more established than it is.
The framework: because Malassezia metabolises fatty acids of particular chain lengths, products containing fatty acids, most esters, and many plant oils can feed it, while a specific set of ingredients cannot. This produced the widely circulated rule about avoiding fatty acids in roughly the C11 to C24 range, along with polysorbates and most esters, and the ingredient-checker tools built around it.
What's well supported: Malassezia is lipid-dependent, it cannot synthesise its own fatty acids, and it does metabolise specific chain lengths. Oil-rich products do aggravate the condition in practice. Squalane and mineral oil are not metabolised by it — squalane is a hydrocarbon, not a fatty acid — which is why they show up as the safe emollients.
What's overstated: the precise chain-length cutoffs are extrapolated from laboratory growth studies rather than established as clinical formulation guidance, and the ingredient-checker tools apply them with a confidence the underlying evidence doesn't support. A product flagged 'unsafe' will not necessarily flare you, and the lists produce a lot of unnecessary anxiety and unnecessary product-discarding.
The sensible position: treat it as a useful heuristic for narrowing choices during an active flare, not as a law. The antifungal is doing the work; the ingredient list is a supporting measure.
Why It Comes Back
Because Malassezia is normal skin flora, you are not eradicating it — you are suppressing an overgrowth. The literature is blunt about the consequence: relapse almost always occurs when treatment is withdrawn, which is why maintenance is part of the plan rather than a sign of failure.
Practical maintenance looks like using the antifungal once or twice a week indefinitely rather than daily, rather than stopping entirely once it clears.
Address the conditions that favour it. Change out of sweaty clothing promptly rather than sitting in it. Wash pillowcases regularly. Be cautious with heavy occlusive layers over affected areas — this is the one place where slugging is a bad idea, and worth knowing if you've read our guide to it. Reconsider oil-rich products on the affected zones.
And if you are on a long oral antibiotic course for acne, raise this with your prescriber, since that is a recognised contributor and a reason the AAD guidelines favour time-limited antibiotic courses in the first place.
Frequently Asked Questions
How do I know if I have fungal acne or regular acne?+
The most useful single clue is comedones: Malassezia folliculitis doesn't produce blackheads, so if you have them you have at least some acne vulgaris. Other signals are uniform 1-2mm bumps in crops rather than mixed lesion types, itch, a forehead/chest/back distribution, and — most tellingly — no response or worsening on acne treatment. A dermatologist can confirm with a skin scraping.
Do I need to follow 'fungal acne safe' ingredient lists?+
They're a useful heuristic during an active flare, not a law. The underlying biology is real — Malassezia is lipid-dependent and metabolises specific fatty acid chain lengths — but the precise cutoffs used by ingredient checkers are extrapolated from lab growth studies rather than established clinical guidance. The antifungal does the work; the ingredient list supports it.
Why does it keep coming back?+
Because Malassezia is normal skin flora — you're suppressing an overgrowth, not eradicating an invader. Relapse on withdrawal is the expected course, which is why maintenance dosing once or twice weekly is part of the plan rather than evidence that treatment failed.
Author
Glowstice Editorial
The Glowstice editorial team consists of skincare researchers, cosmetic chemists, and science writers dedicated to translating peer-reviewed dermatology into practical guidance for curious consumers.
